中国寄生虫学与寄生虫病杂志 ›› 2006, Vol. 24 ›› Issue (1): 6-26.

• 论著 • 上一篇    下一篇

新药三苯双脒肠溶片治疗肠道线虫感染的效果观察

吴中兴;方悦怡;刘宜升   

  1. 1 江苏省寄生虫病防治研究所 无锡214064; 2 广东省寄生虫病防治研究所 广州510300;3 徐州医学院寄生虫病研究室 徐州221002
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2006-02-28 发布日期:2006-02-28

Effect of a Novel Drug———Enteric Coated Tribendimidine in the Treatment of Intestinal Nematode Infections

WU Zhong-xing1;FANG Yue-yi2;LIU Yi-sheng3   

  1. 1 Jiangsu Provincial Institute of Parasitic Diseases,Wuxi 214064,China; 2 Guangdong Provincial Institute of Parasitic Diseases;Guangzhou 510300,China; 3 Department of Parasitology,Xuzhou Medical College,Xuzhou 221002,China
  • Received:1900-01-01 Revised:1900-01-01 Online:2006-02-28 Published:2006-02-28

摘要: 目的 观察三苯双脒肠溶片对钩虫、蛔虫、鞭虫和蛲虫感染的驱虫效果和可能发生的不良反应。方法 广东、江苏2省4县流行区的单纯钩虫、蛔虫、鞭虫、蛲虫感染者共629例,按统一的临床试验方案,随机双盲治疗522例,开放治疗107例。对钩虫感染者同时作虫卵计数、钩蚴培养及虫种鉴定。以阿苯达唑为对照药物,观察驱虫效果和不良反应。结果 三苯双脒400mg和阿苯达唑400mg顿服,钩虫感染者的虫卵阴转率分别为89.5%(85/95)和70.6%(60/85)(P<0.01),其中对美洲钩虫感染者的虫卵阴转率分别为94·9%(37/39)和76.5%(26/34)(P<0.05);三苯双脒300mg和阿苯达唑400mg顿服,对蛔虫感染者的虫卵阴转率分别为97.4%(114/117)和98.9%(91/92)(P>0.05);三苯双脒400mg×3d和阿苯达唑400mg×3d对鞭虫感染者的虫卵阴转率分别为33.3%(25/75)和56.1%(23/41)(P<0.05);三苯双脒或阿苯达唑200mg顿服对儿童蛲虫感染者的虫卵阴转率分别为74.1%(60/81)和93.0%(40/43)(P<0.05)。治疗过程中未发现明显不良反应。结论 三苯双脒肠溶片治疗钩虫、蛔虫等感染,疗效显著,服用方便,不良反应少而轻微。尤其对美洲钩虫感染的疗效优于阿苯达唑。

关键词: 三苯双脒, 阿苯达唑, 钩虫, 蛔虫, 鞭虫, 蛲虫, 美洲钩虫

Abstract: Objective To study the therapeutic effect and possible adverse effects of tribendimidine enteric coated tablets in the treatment of infections due to hookworms, Ascaris lumbricoides, Trichuris trichiura, Enterobius vermicularis. Methods According to the standard clinical trial design and protocol, pearsons infected with hookworms, Ascaris lumbricoides, Trichuris trichiura, or Enterobius vermicularis respectively, were treated with tribendimidine enteric coated tablets in four counties of Guangdong and Jiangsu Provinces, albendazole was used as control. Results For hookworm infection, the curative rate (eggs negative in the faeces) were 89.5%(85/95) and 70.6%(60/85) with tribendimidine (400 mg) and albendazole(400 mg) respectively; for Ascaris infection, 97.4%(114/117) and 98.9%(91/92) with tribendimidine(300 mg) and albendazole(400 mg) respectively; for Trichuris infection,33.3%(25/75) and 56.1%(23/41) with tribendimidine(400 mg/day for 3 days) and albendazole(400 mg/day for 3 days) respectively; for Enterobius infection in children, 74.1%(60/81) and 93.0%(40/43) with tribendimidine(200 mg) and albendazole(200 mg) respectively. No considerable side effect was found. Conclusion Tribendimidine is highly active in the treatment of hookworm, Ascaris lumbricoides infections, free of major adverse effect and easy to administer. It is more effective than albendazole for the infection of Necator americanus.

Key words: Tribendimidine, Albendazole, Hookworm, Ascaris lumbricoides, Trichuris trichiura, Enterobius vermicularis, Necator americanus